{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T12:08:41Z","timestamp":1789214921420,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":112,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.urolonc.2024.05.005","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T21:00:50Z","timestamp":1719522050000},"page":"333.e15-333.e20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A 2-center review of histopathology of variants of upper urinary tract urothelial carcinoma and their impact on clinical outcomes"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9844-1799","authenticated-orcid":false,"given":"N.","family":"Giudici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Schoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Genitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rodriguez-Calero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.N.","family":"Thalmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Seiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2024.05.005_bib0001","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ejca.2018.07.005","article-title":"Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018","volume":"103","author":"Ferlay","year":"2018","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.urolonc.2024.05.005_bib0002","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.urolonc.2024.05.005_bib0003","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.juro.2012.05.079","article-title":"Urothelial carcinoma of the bladder and the upper tract: disparate twins","volume":"189","author":"Green","year":"2013","journal-title":"J Urol"},{"issue":"13","key":"10.1016\/j.urolonc.2024.05.005_bib0004","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1002\/cncr.24339","article-title":"Carcinoma of the upper urinary tract: Predictors of survival and competing causes of mortality","volume":"115","author":"Inman","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2024.05.005_bib0005","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.2147\/CMAR.S180606","article-title":"Microscopic hematuria predicts lower stage in patients with upper tract urothelial carcinoma","volume":"10","author":"Qi","year":"2018","journal-title":"Cancer Manag Res"},{"issue":"10","key":"10.1016\/j.urolonc.2024.05.005_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139624","article-title":"Concurrent preoperative presence of hydronephrosis and flank pain independently predicts worse outcome of upper tract urothelial carcinoma","volume":"10","author":"Yeh","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.urolonc.2024.05.005_bib0007","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.urolonc.2009.11.007","article-title":"Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy?","volume":"29","author":"Raman","year":"2011","journal-title":"Urol Oncol"},{"issue":"5","key":"10.1016\/j.urolonc.2024.05.005_bib0008","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1464-410X.2010.09899.x","article-title":"Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma","volume":"108","author":"Messer","year":"2011","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.urolonc.2024.05.005_bib0009","doi-asserted-by":"crossref","first-page":"204.e9","DOI":"10.1016\/j.urolonc.2015.02.010","article-title":"Effect of concomitant variant histology on the prognosis of patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy","volume":"33","author":"Shibing","year":"2015","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.05.005_bib0010","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: Prostate and bladder tumours","volume":"70","author":"Humphrey","year":"2016","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2024.05.005_bib0011","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/JU.0000000000000523","article-title":"Prognostic value of variant histology in upper tract urothelial carcinoma treated with nephroureterectomy: A systematic review and meta-analysis","volume":"203","author":"Mori","year":"2020","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2024.05.005_bib0012","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jasc.2016.04.005","article-title":"The Paris system for reporting urinary cytology: The quest to develop a standardized terminology","volume":"5","author":"Barkan","year":"2016","journal-title":"J Am Soc Cytopathol"},{"issue":"4","key":"10.1016\/j.urolonc.2024.05.005_bib0013","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.eururo.2010.12.042","article-title":"European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update","volume":"59","author":"Roupr\u00eat","year":"2011","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.05.005_bib0014","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.eururo.2020.05.042","article-title":"European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2020 update","volume":"79","author":"Roupr\u00eat","year":"2021","journal-title":"Eur Urol"},{"issue":"16","key":"10.1016\/j.urolonc.2024.05.005_bib0015","doi-asserted-by":"crossref","first-page":"377","DOI":"10.21037\/atm.2019.07.31","article-title":"Impact of squamous differentiation on intravesical recurrence and prognosis of patients with upper tract urothelial carcinoma","volume":"7","author":"Yu","year":"2019","journal-title":"Ann Transl Med"},{"issue":"5","key":"10.1016\/j.urolonc.2024.05.005_bib0016","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/bju.14751","article-title":"Incidence and survival outcomes in patients with upper urinary tract urothelial carcinoma diagnosed with variant histology and treated with nephroureterectomy","volume":"124","author":"Zamboni","year":"2019","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.urolonc.2024.05.005_bib0017","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.euo.2019.09.003","volume":"2","author":"Veskim\u00e4e","year":"2019","journal-title":"Eur Urol Oncol"},{"issue":"3","key":"10.1016\/j.urolonc.2024.05.005_bib0018","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.urolonc.2010.01.001","article-title":"Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy","volume":"30","author":"Wheat","year":"2012","journal-title":"Urol Oncol"},{"issue":"8","key":"10.1016\/j.urolonc.2024.05.005_bib0019","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.ejca.2013.02.001","article-title":"Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy","volume":"49","author":"Xylinas","year":"2013","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.urolonc.2024.05.005_bib0020","doi-asserted-by":"crossref","first-page":"78.e1","DOI":"10.1016\/j.urolonc.2017.10.013","article-title":"Clinical characteristics and outcomes of nonurothelial cell carcinoma of the bladder: Results from the National Cancer Data Base","volume":"36","author":"Royce","year":"2018","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.05.005_bib0021","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2024.05.005_bib0022","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000514759","article-title":"Non-muscle invasive bladder cancer with variant histology: Biological features and clinical implications","volume":"99","author":"Sanguedolce","year":"2021","journal-title":"Oncology"},{"issue":"2","key":"10.1016\/j.urolonc.2024.05.005_bib0023","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.eururo.2012.04.020","article-title":"Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: Results from a retrospective study at the MD Anderson Cancer Center","volume":"64","author":"Lynch","year":"2013","journal-title":"Eur Urol"}],"updated-by":[{"DOI":"10.1016\/j.urolonc.2024.11.016","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000}},{"DOI":"10.1016\/j.urolonc.2026.08.021","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000}}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924004630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924004630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T11:46:15Z","timestamp":1737632775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143924004630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1078143924004630"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.05.005","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.urolonc.2024.11.016","asserted-by":"object"}]},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A 2-center review of histopathology of variants of upper urinary tract urothelial carcinoma and their impact on clinical outcomes","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}